Results 111 to 120 of about 5,052,436 (221)

Correspondence: In-vitro thrombolytic and cytotoxic activity of methanolic extract of Syzygium operculatum leaves

open access: yes, 2015
The existing study was made to investigate the thrombolytic exercise and cytotoxic potential with the methanol extract of Syzygium operculatum leaves. The cytotoxicity had been assessed while using brine shrimp lethality bioassay and also thrombolytic ...
Dr Rahman   +12 more
core  

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, restores blood–brain barrier integrity in a human stem cell‐based model of ischaemic stroke

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 19, Page 5791-5812, October 2026.
Ischaemic stroke is characterised by acute cerebrovascular occlusion and blood–brain barrier (BBB) breakdown. Our results indicated that the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) ameliorated the loss of BBB integrity, changed the morphology of brain endothelial cells, increased the level of basement membrane and ...
Anikó Szecskó   +14 more
wiley   +1 more source

Total Thiols and MDA Levels in Patients with Acute Myocardial Infarction Before and After Reperfusion Therapy

open access: yesOnline Journal of Health & Allied Sciences, 2010
Background: Reactive oxygen species have been implicated in the pathogenesis of ischemic and reperfusion injury. In the current work we have measured malondialdehyde (MDA), total thiols, total CK, CK-MB and AST in ECG proven acute myocardial infarction ...
Suresh Babu   +2 more
doaj  

Platelet Membrane-Coated r‑SAK Improves Thrombolytic Efficacy by Targeting Thrombus

open access: yes
Thrombolytic therapy is one of the most effective treatments for thrombus dissolution and recanalization of blocked vessels in thrombotic diseases. However, the application of the thrombolytic strategy has been limited due to unsatisfactory thrombolytic ...
Chunyue Tan (18390581)   +15 more
core   +1 more source

Ching Wah Silk Filature Coy. : French style

open access: yes, 1894
Item title.An advertisment in English.Shingtoze Agent, issuing ...
Shingtoze Agent
core  

Synergism of thrombolytic agents in vivo.

open access: yes, 1986
The existence of significant synergism between tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA), and between t-PA and urokinase in thrombolysis in vivo is described.
J M Stassen   +3 more
core   +1 more source

Efficacy of Streptokinase as a Thrombolytic Agent Against Plasma-Only In Vitro Thrombi [PDF]

open access: yes
Blood clots, also known as thrombi, can be life-threatening medical emergencies. Blood-contacting medical devices have a tendency to induce thrombus formation, which can result in the failure of the device or other complications associated with ...
Purtle, Allison Faith
core  

Pulmonary thromboembolism with massive vaginal bleeding due to thrombolytic therapy

open access: yes, 2003
Thrombolytic therapy may reduce the morbidity of pulmonary thromboembolism (PTE) and the risk of recurrent disease. The most important complication of thrombolytic therapy is bleeding.
Habesoglu, MA   +4 more
core   +1 more source

Response to thrombolytic agents in acute myocardial infarction in opium abusers versus non-abusers

open access: yesJournal of Research in Pharmacy Practice, 2012
Objective: Coronary artery disease is one of the leading causes of morbidity and mortality in populations. In opium abusers, level of circulating coagulation factors differs from non-abusers. The aim of this study was to evaluate response to thrombolytic
Seyed Mohammad Hashemi Jazi   +2 more
doaj  

Evaluation of Membrane-Stabilizing and Clot-Lysing Activities of the Chloroform Fraction of Rhizomes: An Model With Molecular Docking

open access: yesNatural Product Communications
Objective Cardiovascular diseases (CVDs) remain a primary reason for death, and current thrombolytic agents face significant limitations due to side effects and high costs.
Md. Sabbir Hossain   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy